Anastasia Yemelyanova
![Anastasia Yemelyanova Anastasia Yemelyanova](https://genetherapy-regulatory.com/wp-content/uploads/sites/910/2023/09/Anastasia-Yemelyanova-Headshot-150x150.jpg)
Company: Spark Therapeutics
Job title: Director of Regulatory CMC
Seminars:
Exploring Different Approaches & Expectations in Proving Comparability in a Global Setting 10:00 am
Clarifying the FDA Expectations on Repeat Studies for Non-Clinical Studies Between and Before Phase 3 Exploring Different Global Approaches to Comparability between the FDA, EMA and other Regulatory Bodies Understanding the Depth and Timelines Needed for Comparability Data as Gene Therapy Programs progress to phase 1 and 2 When Resource Burden IncreasesRead more
day: Conference Day Two